A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Phase 1/2 Terminated
73 enrolled
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
Phase 1/2 Terminated
31 enrolled
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Phase 1 Terminated
31 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
STARBURST
Phase 2 Terminated
11 enrolled
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
Phase 1 Terminated
20 enrolled
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Phase 1/2 Terminated
87 enrolled 29 charts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Phase 2 Terminated
54 enrolled 11 charts
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Phase 1 Terminated
55 enrolled
MANTRA
Phase 3 Terminated
175 enrolled 16 charts
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Phase 1 Terminated
9 enrolled 10 charts
TTI-621-03
Phase 2 Terminated
76 enrolled 53 charts
CAR
Phase 1 Terminated
9 enrolled
CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
Phase 1 Terminated
9 enrolled
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
Phase 1 Terminated
74 enrolled
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Phase 1/2 Terminated
89 enrolled 20 charts
Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
Phase 1 Terminated
14 enrolled
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Phase 2 Terminated
99 enrolled 10 charts
LODESTAR
Phase 2 Terminated
83 enrolled 16 charts
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Phase 1/2 Terminated
23 enrolled 15 charts
NBE-002 in Patients With Advanced Solid Tumors
Phase 1/2 Terminated
12 enrolled
VITA
Phase 3 Terminated
32 enrolled 13 charts
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Phase 1 Terminated
56 enrolled
REVEAL
Phase 1/2 Terminated
64 enrolled 22 charts
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Phase 2 Terminated
15 enrolled
Safety Study of MGD009 in B7-H3-expressing Tumors
Phase 1 Terminated
67 enrolled
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Phase 2 Terminated
317 enrolled 27 charts
A Safety Study of SGN-CD47M in Patients With Solid Tumors
Phase 1 Terminated
16 enrolled
IMDZ-C232
Phase 2 Terminated
89 enrolled 24 charts
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Phase 1 Terminated
79 enrolled
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
Phase 1 Terminated
21 enrolled
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Phase 2 Terminated
7 enrolled 7 charts
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
Terminated
5 enrolled
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Phase 2 Terminated
6 enrolled 6 charts
MMS-TM
Terminated
100 enrolled
Patient-Derived Xenograft (PDX) Modeling in Adult Patients With Metastatic or Recurrent Sarcoma
Phase NA Terminated
17 enrolled
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Phase 1 Terminated
24 enrolled 10 charts
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Terminated
167 enrolled